Early classical swine fever virus persistence is associated with cytotoxic and immunoregulatory transcriptional signatures distinct from protective C-strain vaccination
Sara Puente-Marin, Adriana Muñoz-Aguilera, Anibal Asilvera, Cristina Riquelme, Liani Coronado, Yoandry Hinojosa, Saray Heredia, Àlex Cobos, Llilianne Ganges · 2026
Read Early classical swine fever virus persistence is associated with cytotoxic and immunoregulatory transcriptional signatures distinct from protective C-strain vaccination by Sara Puente-Marin, Adriana Muñoz-Aguilera, Anibal Asilvera, Cristina Riquelme, Liani Coronado, Yoandry Hinojosa, Saray Heredia, Àlex Cobos, Llilianne Ganges (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13645531.txt.
Description
Sara Puente-Marin and eight colleagues present a study of the first immune events when classical swine fever virus sets up lifelong persistence in newborn piglets. Persistently infected pigs look healthy while shedding virus, which defeats control programs.
The team compared blood cell gene activity at day seven between piglets infected with a persistence-causing strain and piglets given the protective C-strain vaccine, before symptoms or antibodies appeared. Infected animals carried high virus loads and strong interferon signals, with pathways for killing and immune regulation switched on and antigen display turned down. Persistence, the authors argue, begins despite vigorous antiviral activation, through regulation that blunts control.
Catalog record
| CREATOR | Sara Puente-Marin, Adriana Muñoz-Aguilera, Anibal Asilvera, Cristina Riquelme, Liani Coronado, Yoandry Hinojosa, Saray Heredia, Àlex Cobos, Llilianne Ganges |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |